Interactions between dopamine and 5-HT3 receptors suggest new treatments for psychosis and drug addiction.
Tricklebank
M D
MD
D000818:Animals; D006801:Humans; D011618:Psychotic Disorders / Q000188:drug therapy*; D011954:Receptors, Dopamine / Q000187:drug effects*; D011985:Receptors, Serotonin / Q000187:drug effects*; D012702:Serotonin Antagonists / Q000627:therapeutic use; D019966:Substance-Related Disorders / Q000188:drug therapy*
D011954:Receptors, Dopamine; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists